Melexis (MELE) Q2 2025 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2025 earnings summary
30 Jul, 2025Executive summary
Q2 2025 sales reached €211.6 million, down 14% year-over-year but up 7% sequentially, with net profit at €37.8 million, a 23% decline year-over-year but up 54% from Q1.
Gross margin for Q2 2025 was 39.0%, down from 44.3% in Q2 2024, and EBIT margin was 16.8%, both lower year-over-year but improved sequentially.
Automotive applications accounted for 88% of Q2 sales, with strong growth in powertrain and interior lighting; non-automotive contributed 12%.
New product launches included temperature, thermographic infrared, and magnetic position sensors for automotive, industrial, and medical sectors.
The company maintains a strong dividend yield and active share buyback program.
Financial highlights
H1 2025 sales totaled €409.8 million, down 16% year-over-year; Q2 2025 sales were €211.6 million.
Q2 2025 net income was €37.8 million (EPS €0.94), down from €1.21 in Q2 2024; H1 2025 net income was €62.4 million (EPS €1.54), down 39% year-over-year.
Q2 2025 EBITDA was €50.1 million (23.7% margin), down 35% year-over-year but up 21% sequentially.
Dividend of €96 million paid in H1 2025; €8 million spent on share buybacks.
EUR/USD exchange rate negatively impacted Q2 sales by 2% year-over-year and 3% sequentially.
Outlook and guidance
Q3 2025 sales expected between €210–215 million; full-year 2025 sales forecasted at €835–845 million.
Gross margin for the year guided around 39%, operating margin around 16%, assuming EUR/USD rate of 1.17.
Full-year 2025 CAPEX expected to be €40 million, revised down from €50 million.
Guidance includes short-term orders; visibility remains limited due to customer order patterns.
Latest events from Melexis
- 2025 sales fell 10%, profit 34%; Q4 rebounded, 2026 H2 growth and margin recovery expected.MELE
Q4 20254 Feb 2026 - Accelerated innovation, market expansion, and robust financial targets drive future growth.MELE
CMD 20253 Feb 2026 - Q2 2024 sales up 4% year-over-year, with strong margins and lower CAPEX guidance.MELE
Q2 20242 Feb 2026 - Q3 sales steady at €247.9M, but full-year outlook cut amid inventory and market headwinds.MELE
Q3 202417 Jan 2026 - Q1 2025 sales dropped 18% year-over-year, with margins pressured and China strategy advancing.MELE
Q1 202524 Dec 2025 - 2024 sales and profits declined, but innovation and design wins support a mid-2025 recovery.MELE
Q4 202416 Dec 2025 - Q3 sales reached €215.3M, down 13% year-over-year, with gross margin at 38.8%.MELE
Q3 202529 Oct 2025